BIOMAT Database Logo BIOMAT Database Logo

Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis. 1996

K K Kirchner, and J S Wagener, and T Z Khan, and S C Copenhaver, and F J Accurso
Department of Pediatrics, University of Colorado School of Medicine, The Children's Hospital, Denver, USA.

Airway inflammation in children younger than 5 yr of age is difficult to assess, particularly in patients with cystic fibrosis (CF). Furthermore, determining responses to therapies is often subjective in infants, especially those with CF. To determine whether airway DNA levels could be used as an index of airway inflammation, we measured DNA levels in bronchoalveolar lavage fluid (BALF), using a Hoechst dye-binding assay. BALF DNA levels and neutrophils from 16 infants with CF were compared with levels obtained from seven older CF patients and nine control children who underwent bronchoalveolar lavage for evaluation of other pulmonary diseases. BALF DNA was increased in both infants (3.2 +/- 0.7 microg/ml) and older patients with CF (5.4 +/- 0.9 microg/ml) compared with the controls (0.7 +/- 0.2 microg/ml) (mean +/- SEM). BALF DNA levels were not significantly different between infants and older patients with CF. BALF neutrophil counts in CF patients were significantly higher than in controls. Furthermore, BALF DNA levels and total neutrophil counts in infants with CF correlated positively with one another. We conclude that: (1) DNA levels were easily quantifiable in BALF of young children; (2) DNA levels in BALF from CF patients were greater than in a group of children with other pulmonary diseases, and that in some infants with CF, BALF DNA levels were equivalent to those of much older patients with CF; (3) DNA levels in BALF correlate with BALF neutrophil number, an index of inflammation; and (4) some infants with CF have increased levels of DNA in BALF, which may justify a clinical trial of aerosolized rhDNase in this population.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K K Kirchner, and J S Wagener, and T Z Khan, and S C Copenhaver, and F J Accurso
Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis.
January 2016, PloS one,
K K Kirchner, and J S Wagener, and T Z Khan, and S C Copenhaver, and F J Accurso
Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis.
February 2001, The European respiratory journal,
K K Kirchner, and J S Wagener, and T Z Khan, and S C Copenhaver, and F J Accurso
Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients.
February 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals,
K K Kirchner, and J S Wagener, and T Z Khan, and S C Copenhaver, and F J Accurso
Bronchoalveolar lavage fluid obtained from smokers exhibits increased monocyte chemokinetic activity.
March 1991, Journal of applied physiology (Bethesda, Md. : 1985),
K K Kirchner, and J S Wagener, and T Z Khan, and S C Copenhaver, and F J Accurso
Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis.
December 2007, Proceedings of the National Academy of Sciences of the United States of America,
K K Kirchner, and J S Wagener, and T Z Khan, and S C Copenhaver, and F J Accurso
Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis.
January 1998, American journal of respiratory cell and molecular biology,
K K Kirchner, and J S Wagener, and T Z Khan, and S C Copenhaver, and F J Accurso
Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma.
June 1993, The American review of respiratory disease,
K K Kirchner, and J S Wagener, and T Z Khan, and S C Copenhaver, and F J Accurso
Nocardia farcinica isolated from bronchoalveolar lavage fluid of a child with cystic fibrosis.
September 2007, The Pediatric infectious disease journal,
K K Kirchner, and J S Wagener, and T Z Khan, and S C Copenhaver, and F J Accurso
Increased levels of oxidized methionine residues in bronchoalveolar lavage fluid proteins from patients with idiopathic pulmonary fibrosis.
February 1991, The American review of respiratory disease,
K K Kirchner, and J S Wagener, and T Z Khan, and S C Copenhaver, and F J Accurso
Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis.
March 1997, The Journal of infectious diseases,
Copied contents to your clipboard!